CEL-SCI CORPORATION

CVM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $264.0K $159.6K $254.6K $956.2K
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $15.6M $17.4M $19.2M $15.3M $12.7M $10.4M $11.7M $11.9M
SG&A Expense $5.8M $6.5M $13.9M $10.7M $7.0M $6.6M $6.7M $6.3M
Operating Income $-21.4M $-23.6M $-32.4M $-25.7M $-19.9M $-17.2M $-18.0M $-18.6M
Operating Margin -9,721.4% -12,450.1% -6,772.3% -1,881.0%
Interest Expense $130.0K $163.8K $170.4K $262.2K $323.0K $162.3K
Pretax Income
Income Tax Expense
Net Income $-14.4M $-11.5M $-34.7M $-27.4M $-9.2M $-15.5M $-25.7M $10.5M
Net Margin -10,359.6% -5,746.8% -6,078.8% -2,689.1%
EPS (Basic) $-0.46 $-0.59 $-2.63 $-3.03 $-0.08 $-0.18 $-0.32 $0.01
EPS (Diluted) $-0.48 $-0.59 $-2.63 $-3.05 $-0.17 $-0.20 $-0.37 $-0.02
Shares Outstanding (Basic) 31.6M 19.5M 13.2M 365.4M 199.0M 1.01B 834.0M 808.4M
Shares Outstanding (Diluted) 31.6M 19.5M 13.2M 365.4M 199.0M 1.01B 834.0M 808.4M
Dividends Per Share
← Newer Page 2 of 3 Older →